The efficacy of first-line chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The efficacy of first-line chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis

Published:2018-06 Issue:11 Volume:6 Page:201-201
ISSN:2305-5839
Container-title:Annals of Translational Medicine
language:
Short-container-title:Ann. Transl. Med

Author:

Ma Shu-Xiang,Zhou Ting,Huang Yan,Yang Yun-Peng,Zhan Jian-Hua,Zhang Ya-Xiong,Zhang Zhong-Han,Zhao Yuan-Yuan,Fang Wen-Feng,Ma Yu-Xiang,Chen Li-Kun,Zhao Hong-Yun,Zhang Li

Publisher

AME Publishing Company

Subject

General Medicine

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Cell-based Immunotherapy in The Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma – A Systematic Review and Meta-analysis;Oral Oncology;2024-05

2. Clinical features and prognostic factors of nasopharyngeal carcinoma with brain metastases;Oral Oncology;2024-04

3. Cost-effectiveness of pembrolizumab versus chemotherapy in patients with platinum-pretreated, recurrent or metastatic nasopharyngeal cancer;Cost Effectiveness and Resource Allocation;2024-01-24

4. International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors;International Forum of Allergy & Rhinology;2024-01-02

5. Camrelizumab plus taxanes and cisplatin (TP) chemotherapy or TP chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma;2023-04-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP